• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白基因组学分析揭示了甲状腺乳头状癌中的 TFG-RET 基因融合和可用药靶。

Proteogenomics analysis unveils a TFG-RET gene fusion and druggable targets in papillary thyroid carcinomas.

机构信息

Cell Biology Unit, University Medical Center of the Johannes Gutenberg University Mainz, 55131, Mainz, Germany.

Institute of Immunology, University Medical Center of the Johannes Gutenberg University Mainz, 55131, Mainz, Germany.

出版信息

Nat Commun. 2020 Apr 28;11(1):2056. doi: 10.1038/s41467-020-15955-w.

DOI:10.1038/s41467-020-15955-w
PMID:32345963
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7188865/
Abstract

Papillary thyroid cancer (PTC) is the most common type of endocrine malignancy. By RNA-seq analysis, we identify a RET rearrangement in the tumour material of a patient who does not harbour any known RAS or BRAF mutations. This new gene fusion involves exons 1-4 from the 5' end of the Trk fused Gene (TFG) fused to the 3' end of RET tyrosine kinase leading to a TFG-RET fusion which transforms immortalized human thyroid cells in a kinase-dependent manner. TFG-RET oligomerises in a PB1 domain-dependent manner and oligomerisation of TFG-RET is required for oncogenic transformation. Quantitative proteomic analysis reveals the upregulation of E3 Ubiquitin ligase HUWE1 and DUBs like USP9X and UBP7 in both tumor and metastatic lesions, which is further confirmed in additional patients. Expression of TFG-RET leads to the upregulation of HUWE1 and inhibition of HUWE1 significantly reduces RET-mediated oncogenesis.

摘要

甲状腺乳头状癌(PTC)是最常见的内分泌恶性肿瘤。通过 RNA 测序分析,我们在一名患者的肿瘤组织中发现了一种 RET 重排,该患者不携带任何已知的 RAS 或 BRAF 突变。这种新的基因融合涉及 Trk 融合基因(TFG)5' 端的外显子 1-4 与 RET 酪氨酸激酶的 3' 端融合,导致 TFG-RET 融合,以激酶依赖的方式转化永生化人甲状腺细胞。TFG-RET 以 PB1 结构域依赖性方式寡聚化,TFG-RET 的寡聚化是致癌转化所必需的。定量蛋白质组学分析显示,E3 泛素连接酶 HUWE1 和 DUBs(如 USP9X 和 UBP7)在肿瘤和转移病灶中上调,在其他患者中也得到了进一步证实。TFG-RET 的表达导致 HUWE1 的上调,而抑制 HUWE1 则显著降低 RET 介导的致癌作用。

相似文献

1
Proteogenomics analysis unveils a TFG-RET gene fusion and druggable targets in papillary thyroid carcinomas.蛋白基因组学分析揭示了甲状腺乳头状癌中的 TFG-RET 基因融合和可用药靶。
Nat Commun. 2020 Apr 28;11(1):2056. doi: 10.1038/s41467-020-15955-w.
2
Novel rearrangements involving the RET gene in papillary thyroid carcinoma.甲状腺乳头状癌中涉及RET基因的新型重排
Cancer Genet. 2019 Jan;230:13-20. doi: 10.1016/j.cancergen.2018.11.002. Epub 2018 Nov 13.
3
, , , , and Fusions in a Large Cohort of Pediatric Papillary Thyroid Carcinomas.,,,, 和 融合在一大群儿科乳头状甲状腺癌中。
Thyroid. 2020 Dec;30(12):1771-1780. doi: 10.1089/thy.2019.0802. Epub 2020 Jul 1.
4
RET/PTC Gene Rearrangements in Thyroid Carcinogenesis: Assessment and Clinico-Pathological Correlations.RET/PTC 基因重排在甲状腺癌发生中的作用:评估及其与临床病理的相关性。
Pathol Oncol Res. 2020 Jan;26(1):507-513. doi: 10.1007/s12253-018-0540-3. Epub 2018 Nov 22.
5
Oncogenic Properties of the Antisense lncRNA in - and -Driven Papillary Thyroid Carcinomas.反义长链非编码 RNA 在 和 驱动的甲状腺乳头状癌中的致癌特性。
Cancer Res. 2019 May 1;79(9):2124-2135. doi: 10.1158/0008-5472.CAN-18-2520. Epub 2019 Mar 12.
6
Detection of a novel type of RET rearrangement (PTC5) in thyroid carcinomas after Chernobyl and analysis of the involved RET-fused gene RFG5.切尔诺贝利事故后甲状腺癌中新型RET重排(PTC5)的检测及相关RET融合基因RFG5的分析
Cancer Res. 1998 Jan 15;58(2):198-203.
7
NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States.美国东北部儿童甲状腺乳头状癌中的NTRK融合致癌基因
Cancer. 2016 Apr 1;122(7):1097-107. doi: 10.1002/cncr.29887. Epub 2016 Jan 19.
8
BRAF mediates RET/PTC-induced mitogen-activated protein kinase activation in thyroid cells: functional support for requirement of the RET/PTC-RAS-BRAF pathway in papillary thyroid carcinogenesis.BRAF介导甲状腺细胞中RET/PTC诱导的丝裂原活化蛋白激酶激活:对甲状腺乳头状癌发生中RET/PTC-RAS-BRAF途径需求的功能支持。
Endocrinology. 2006 Feb;147(2):1014-9. doi: 10.1210/en.2005-0280. Epub 2005 Oct 27.
9
High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines.BRAF基因突变在甲状腺乳头状癌和甲状腺肿瘤细胞系中的高发生率。
Cancer Res. 2003 Aug 1;63(15):4561-7.
10
Concomitant RAS, RET/PTC, or BRAF mutations in advanced stage of papillary thyroid carcinoma.甲状腺乳头状癌晚期伴发RAS、RET/PTC或BRAF基因突变。
Thyroid. 2014 Aug;24(8):1256-66. doi: 10.1089/thy.2013.0610. Epub 2014 Jun 10.

引用本文的文献

1
Venetoclax combined with ATRA shows promising therapeutic potential for TFG:: RARA variant APL: a case report.维奈托克联合全反式维甲酸对TFG::RARA变异型急性早幼粒细胞白血病显示出有前景的治疗潜力:一例病例报告
Front Oncol. 2025 May 2;15:1529640. doi: 10.3389/fonc.2025.1529640. eCollection 2025.
2
Ubiquitin-modifying enzymes in thyroid cancer:Mechanisms and functions.甲状腺癌中的泛素修饰酶:机制与功能
Heliyon. 2024 Jul 2;10(13):e34032. doi: 10.1016/j.heliyon.2024.e34032. eCollection 2024 Jul 15.
3
Dramatic response to crizotinib through MET phosphorylation inhibition in rare TFG-MET fusion advanced squamous cell lung cancer.

本文引用的文献

1
ANKRD26-RET - A novel gene fusion involving RET in papillary thyroid carcinoma.ANKRD26-RET——一种在甲状腺乳头状癌中涉及RET的新型基因融合。
Cancer Genet. 2019 Oct;238:10-17. doi: 10.1016/j.cancergen.2019.07.002. Epub 2019 Jul 5.
2
Novel rearrangements involving the RET gene in papillary thyroid carcinoma.甲状腺乳头状癌中涉及RET基因的新型重排
Cancer Genet. 2019 Jan;230:13-20. doi: 10.1016/j.cancergen.2018.11.002. Epub 2018 Nov 13.
3
Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013.1974 - 2013年美国甲状腺癌发病率和死亡率趋势
在罕见的TFG-MET融合晚期肺鳞状细胞癌中,通过抑制MET磷酸化对克唑替尼产生显著反应。
Oncologist. 2025 Jan 17;30(1). doi: 10.1093/oncolo/oyae166.
4
Mapping the lymph node metastasis landscape: A bibliometric Odyssey of papillary thyroid carcinoma publications (2012-2022).绘制淋巴结转移图谱:乳头状甲状腺癌出版物的文献计量学历程(2012 - 2022年)
Heliyon. 2024 May 16;10(10):e31398. doi: 10.1016/j.heliyon.2024.e31398. eCollection 2024 May 30.
5
Phase separation underlies signaling activation of oncogenic NTRK fusions.相分离为致癌性 NTRK 融合物的信号激活奠定基础。
Proc Natl Acad Sci U S A. 2023 Oct 17;120(42):e2219589120. doi: 10.1073/pnas.2219589120. Epub 2023 Oct 9.
6
Advances in transcriptomics and proteomics in differentiated thyroid cancer: An updated perspective (Review).分化型甲状腺癌的转录组学和蛋白质组学进展:最新观点(综述)
Oncol Lett. 2023 Jul 27;26(3):396. doi: 10.3892/ol.2023.13982. eCollection 2023 Sep.
7
Small Molecule Inhibitors as Therapeutic Agents Targeting Oncogenic Fusion Proteins: Current Status and Clinical.小分子抑制剂作为靶向致癌融合蛋白的治疗剂:现状和临床应用。
Molecules. 2023 Jun 9;28(12):4672. doi: 10.3390/molecules28124672.
8
[Clinical significance of multigene assay in papillary thyroid carcinoma].多基因检测在甲状腺乳头状癌中的临床意义
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2023 May;37(5):375-379. doi: 10.13201/j.issn.2096-7993.2023.05.011.
9
Kinase regulation by liquid-liquid phase separation.液-液相分离调控激酶。
Trends Cell Biol. 2023 Aug;33(8):649-666. doi: 10.1016/j.tcb.2022.11.009. Epub 2022 Dec 15.
10
Changes in TFG gene expression in bovine leucocytes transformed by .经……转化的牛白细胞中TFG基因表达的变化 。 你提供的原文似乎不完整,“by”后面缺少具体内容。
Front Vet Sci. 2022 Oct 20;9:997294. doi: 10.3389/fvets.2022.997294. eCollection 2022.
JAMA. 2017 Apr 4;317(13):1338-1348. doi: 10.1001/jama.2017.2719.
4
Trends and Predictors of Chemotherapy Use among Thyroid Cancer Patients in the National Cancer Database (2004-2013).国家癌症数据库(2004 - 2013年)中甲状腺癌患者化疗使用情况的趋势及预测因素
Eur Thyroid J. 2016 Dec;5(4):268-276. doi: 10.1159/000449379. Epub 2016 Oct 21.
5
HUWE1 is a critical colonic tumour suppressor gene that prevents MYC signalling, DNA damage accumulation and tumour initiation.HUWE1是一种关键的结肠肿瘤抑制基因,可阻止MYC信号传导、DNA损伤积累和肿瘤起始。
EMBO Mol Med. 2017 Feb;9(2):181-197. doi: 10.15252/emmm.201606684.
6
Analysis of protein-coding genetic variation in 60,706 humans.对60706名人类的蛋白质编码基因变异进行分析。
Nature. 2016 Aug 18;536(7616):285-91. doi: 10.1038/nature19057.
7
Label-free quantification in ion mobility-enhanced data-independent acquisition proteomics.无标签定量在离子淌度增强型数据非依赖性采集蛋白质组学中的应用。
Nat Protoc. 2016 Apr;11(4):795-812. doi: 10.1038/nprot.2016.042. Epub 2016 Mar 24.
8
SnapShot: Expanding the Ubiquitin Code.简讯:拓展泛素密码
Cell. 2016 Feb 25;164(5):1074-1074.e1. doi: 10.1016/j.cell.2016.02.019.
9
Risk Factors for Central Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis.CN0 期乳头状甲状腺癌中央淋巴结转移的危险因素:一项系统评价与 Meta 分析
PLoS One. 2015 Oct 2;10(10):e0139021. doi: 10.1371/journal.pone.0139021. eCollection 2015.
10
The emerging complexity of gene fusions in cancer.癌症中基因融合的新兴复杂性。
Nat Rev Cancer. 2015 Jun;15(6):371-81. doi: 10.1038/nrc3947.